Market closed

Vaxart/$VXRT

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Vaxart

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Ticker

$VXRT
Trading on

Industry

Biotechnology

Employees

109
Website

Vaxart Metrics

BasicAdvanced
$130M
Market cap
-
P/E ratio
-$0.40
EPS
0.70
Beta
-
Dividend rate
$130M
0.7
$1.54
$0.52
1.4M
0.827
0.776
25.492
33.716
-24.56%
-32.91%
-103.37%
6.144
1.89
2.15
-2.005
303.27%
-36.02%
142.59%
-9.54%

What the Analysts think about Vaxart

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Vaxart stock.

Vaxart Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Vaxart Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $VXRT

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Vaxart stock?

Vaxart (VXRT) has a market cap of $130M as of December 06, 2024.

What is the P/E ratio for Vaxart stock?

The price to earnings (P/E) ratio for Vaxart (VXRT) stock is 0 as of December 06, 2024.

Does Vaxart stock pay dividends?

No, Vaxart (VXRT) stock does not pay dividends to its shareholders as of December 06, 2024.

When is the next Vaxart dividend payment date?

Vaxart (VXRT) stock does not pay dividends to its shareholders.

What is the beta indicator for Vaxart?

Vaxart (VXRT) has a beta rating of 0.7. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.